Publications by authors named "G S Gulsin"

Aims: Patients with atrial fibrillation (AF) are thought to have an attenuated response to adenosine during vasodilator stress testing. We sought to investigate the haemodynamic and hyperaemic effects of adenosine in patients with AF undergoing adenosine-stress cardiovascular magnetic resonance (CMR) assessment.

Methods And Results: We retrospectively examined 318 patients referred for clinical adenosine-stress CMR (AF = 158, sinus rhythm [SR] = 160).

View Article and Find Full Text PDF

Background: Coronary microvascular dysfunction (CMD) is a significant complication in type 2 diabetes (T2D) and may be more common in women. We aimed to evaluate the sex differences and sex-specific clinical determinants of CMD in adults with T2D without prevalent cardiovascular disease.

Methods: Single center pooled analysis of four prospective studies comparing asymptomatic people with T2D and controls.

View Article and Find Full Text PDF
Article Synopsis
  • Sodium-glucose co-transporter 2 inhibitors (SGLT2i), particularly dapagliflozin, are believed to improve weight loss, cardiovascular health, and glycaemic control, though their effects on physical function are unclear.
  • The Dapagliflozin, Exercise Training and PhysicAl Function trial will compare the effects of dapagliflozin alone, dapagliflozin with exercise, and diet control on physical function in adults with type 2 diabetes and low physical fitness.
  • The study will analyze various outcomes over 24 weeks, including physical performance, cardiac function, and metabolic health, and has received ethical approval for its research methods.
View Article and Find Full Text PDF

Metformin is an antihyperglycemic used to treat type 2 diabetes mellitus (T2DM). Patients with T2DM are at increased risk of cardiovascular disease. We explored the association between metformin use and cardiovascular magnetic resonance (CMR) derived stress myocardial blood flow (MBF), myocardial perfusion reserve (MPR) and major adverse cardiovascular events (MACE; all cause death, MI, stroke, heart failure hospitalisation and coronary revascularisation) in patients with T2DM.

View Article and Find Full Text PDF